КЛИНИЧЕСКИЕ РЕКОМЕНДАЦИИ ЕВРОПЕЙСКОГО ОБЩЕСТВА КАРДИОЛОГОВ ПО ЛЕЧЕНИЮ ПАЦИЕНТОВ С СУПРАВЕНТРИКУЛЯРНЫМИ ТАХИКАРДИЯМИ-2019: ЧТО НОВОГО?
Аннотация
В данной статье представлен обзор клинических рекомендаций Европейского общества кардиологов по лечению пациентов с суправентрикулярными тахикардиями, разработанных совместно с Европейской ассоциацией специалистов по детской кардиологии и врожденным порокам сердца, представленных во время Европейского конгресса кардиологов в Париже 31 августа 2019 г. Новые рекомендации затрагивают вопросы диагностики, неотложного купирования и длительной терапии всех суправентрикулярных тахикардий, за исключением фибрилляции предсердий, и включают главы, посвященные терапии суправентрикулярных нарушений ритма у пациентов с врожденными пороками сердца, тахи-индуцированной кардиомиопатией, у беременных женщин. Особое внимание уделяется применению радиочастотной аблации как наиболее современной, эффективной и динамично развивающейся методике эрадикации аритмий.
Литература
Brugada J, Katritsis DK, Arbelo E, Arribas F, Bax JJ, Blomström-Lundqvist C, Calkins H, Corrado D, Deftereos SG, Diller G-P, Gomez-Doblas JJ, Gorenek B, Grace A, Ho SY, Kaski J-C, Kuck K-H, Lambiase PD, Sacher F, Sarquella-Brugada G, Suwalski P, Zaza A. 2019 ESC Guidelines for the management of patients with supraventricular tachycardia. The Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC): Developed in collaboration with the Association for European Paediatric and Congenital Cardiology (AEPC). European Heart Journal. 2019;41(5):655-720. http://doi.org/10.1093/eurheartj/ehz467.
Orejarena LA, Vidaillet H, De Stefano F, Nordstrom DL, Vierkant RA, Smith PN, Hayes JJ. Paroxysmal supraventricular tachycardia in the general population. Journal of the American College of Cardiology. 1998;31(1):150-157. http://doi.org/10.1016/s0735-1097(97)00422-1.
Chang S-H, Kuo C-F, Chou I-J, See L-C, Yu K-H, Luo S-F, Chiou M-J, Zhang W, Doherty M, Wen M-S, Chen W-J, Yeh Y-H. Outcomes associated with paroxysmal supraventricular tachycardia during pregnancy. Circulation. 2017;135(6):616-618. http://doi.org/10.1161/CIRCULATIONAHA.116.025064.
Porter MJ, Morton JB, Denman R, Lin AC, Tierney S, Santucci PA, Cai JJ, Madsen N, Wilber DJ. Influence of age and gender on the mechanism of supraventricular tachycardia. Heart Rhythm. 2004;1(4):393-396. http://doi.org/10.1016/j.hrthm.2004.05.007.
Granada J, Uribe W, Chyou P-H, Maassen K, Vierkant R, Smith PN, Hayes J, Eaker E, Vidaillet H. Incidence and predictors of atrial flutter in the general population. Journal of the American College of Cardiology. 2010;36(7):2242-2246. http://doi.org/10.1016/s0735-1097(00)00982-7.
Skov MW, Rasmussen PV, Ghouse J, Hansen SM, Graff C, Olesen MS, Pietersen A, Torp-Pedersen C, Haunsø S, Køber L, Svendsen JH, Holst AG, Nielsen JB. Electrocardiographic preexcitation and risk of cardiovascular morbidity and mortality. Results from the Copenhagen ECG Study. Circulation: Arrhythmia and Electrophysiology. 2017;10(6):e004778. http://doi.org/10.1161/CIRCEP.116.004778.
Gopinathannair R, Etheridge SP, Marchlinski FE, Spinale FG, Lakkireddy D, Olshansky B. Arrhythmia-induced cardiomyopathies: mechanisms, recognition, and management. Journal of the American College of Cardiology. 2015;66(15):1714-1728. http://doi.org/10.1016/j.jacc.2015.08.038.
Ellis ER, Josephson ME. What about tachycardia-induced cardiomyopathy? Arrhythmia & Electrophysiology Review. 2013;2(2):82-90. http://doi.org/10.15420/aer.2013.2.2.82.
Ellis ER, Josephson ME. Heart failure and tachycardia-induced cardiomyopathy. Current Heart Failure Reports. 2013;10(4):296-306. http://doi.org/10.3238/arztebl.2018.0335.
Blomström-Lundqvist C, Scheinman MM, Aiot EM, Alpert JS, Calkins H, Camm JA, Campbell WB, Haines DE, Kuck KH, Lerman BB, Miller DD, Shaeffer JrCW, Stevenson WG, Tomaselli GF, Antman EM, Smith SCJr, Alpert JS, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Hiratzka LF, Hunt SA, Jacobs AK, Russell ROJr, et al. 2003 ACC/AHA/ESC Guidelines for the Management of Patients With Supraventricular Arrhythmias. European Heart Journal. 2003;24(20):1857-1897. http://doi.org/10.1016/j.jacc.2003.08.013.
Smith GD, Fry MM, Taylor D, Morgans A, Cantwell K. Effectiveness of the Valsalva Manoeuvre for reversion of supraventricular tachycardia. Cochrane Database Systematic Review. 2015;2:CD009502. http://doi.org/10.1002/14651858.CD009502.pub3.
Stambler BS, Dorian P, Sager PT, Wight D, Douville P, Potvin D, Shamszad P, Haberman RJ, Kuk RS, Lakkireddy DR, Teixeira JM, Bilchick KC, Damle RS, Bernstein RC, Lam WW, O’Neill G, Noseworthy PA, Venkatachalam KL, Coutu B, Mondesert B, Plat F. Etripamil nasal spray for rapid conversion of supraventricular tachycardia to sinus rhythm. Journal of the American College of Cardiology. 2018;72(5):489-497. http://doi.org/10.1016/j.jacc.2018.04.082.
Brubaker S, Long B, Koyfman A. Alternative treatment options for atrioventricular-nodal-reentry tachycardia: an emergency medicine review. Journal of Emergency Medicine. 2018;54(2):198-206. http://doi.org/10.1016/j.jemermed.2017.10.003.
Crijns HJ, Lie KI. Haemodynamic deterioration after treatment with adenosine. British Heart Journal. 1995;73(1):103.
Ortiz M, Martin A, Arribas F, Coll-Vinent B, Del Arco C, Peinado R, Almendral J. Randomized comparison of intravenous procainamide vs. intravenous amiodarone for the acute treatment of tolerated wide QRS tachycardia: the Procamio study. European Heart Journal. 2017;38(17):1329-1335. http://doi.org/10.1093/eurheartj/ehw230.
Ptaszynski P, Kaczmarek K, Ruta J, Klingenheben T, Wranicz JK. Metoprolol succinate vs. ivabradine in the treatment of inappropriate sinus tachycardia in patients unresponsive to previous pharmacological therapy. Europace. 2013;15(1):116-121. http://doi.org/10.1093/europace/eus204.
Cappato R, Castelvecchio S, Ricci C, Bianco E, VitaliSerdoz L, Gnecchi-Ruscone T, Pittalis M, De Ambroggi L, Baruscotti M, Gaeta M, Furlanello F, Di Francesco D, Lupo PP. Clinical efficacy of ivabradine in patients with inappropriate sinus tachycardia: a prospective, randomized, placebo-controlled, double-blind, crossover evaluation. Journal of the American College of Cardiology. 2012;60(15):1323-1329. http://doi.org/10.1016/j.jacc.2012.06.031.
Bryarly M, Phillips LT, Fu Q, Vernino S, Levine BD. Postural orthostatic tachycardia syndrome: JACC Focus Seminar. Journal of the American College of Cardiology. 2019;73(10):1207-1228. http://doi.org/10.1016/j.jacc.2018.11.059.
Tomichi Y, Kawano H, Mukaino A, Chiba A, Doi Y, Arakawa S, Ishimatsu T, Fukae S, Abiru N, Maemura K. Postural orthostatic tachycardia in a patient with type 2 diabetes with diabetic neuropathy. International Heart Journal. 2018;59(6):1488-1490. http://doi.org/10.1536/ihj.17-628.
Spector P, Reynolds MR, Calkins H, Sondhi M, Xu Y, Martin A, Williams CJ, Sledge I. Meta-analysis of ablation of atrial flutter and supraventricular tachycardia. American Journal of Cardiology. 2009;104(5):671-677. http://doi.org/10.1016/j.amjcard.2009.04.040.
Bohnen M, Stevenson WG, Tedrow UB, Michaud GF, John RM, Epstein LM, Albert CM, Koplan BA. Incidence and predictors of major complications from contemporary catheter ablation to treat cardiac arrhythmias. Heart Rhythm. 2011;8(11):1661-1666. http://doi.org/10.1016/j.hrthm.2011.05.017.
Keegan R, Aguinaga L, Fenelon G, Uribe W, RodriguezDiez G, Scanavacca M, Patete M, Carhuaz RZ, Labadet C, De Zuloaga C, Pozzer D, Scazzuso F. The first Latin American Catheter Ablation Registry. Europace. 2015;17(5):794-800. http://doi.org/10.1093/europace/euu322.
Steinbeck G, Sinner MF, Lutz M, Müller-Nurasyid M, Kääb S, Reinecke H. Incidence of complications related to catheter ablation of atrial fibrillation and atrial flutter: a nationwide in-hospital analysis of administrative data for Germany in 2014. European Heart Journal. 2018;39(45):4020-4029. http://doi.org/10.1093/eurheartj/ehy452.
König S, Ueberham L, Schuler E, Wiedemann M, Reithmann C, Seyfarth M, Sause A, Tebbenjohanns J, Schade A, Shin DI, Staudt A, Zacharzowsky U, Andrie R, Wetzel U, Neuser H, Wunderlich C, Kuhlen R, Tijssen JGP, Hindricks G, Bollmann A. In-hospital mortality of patients with atrial arrhythmias: insights from the Germanwide Helios hospital network of 161 502 patients and 34 025 arrhythmia-related procedures. European Heart Journal. 2018;39(44):3947-3957. http://doi.org/10.1093/eurheartj/ehy528.
Katritsis DG, Zografos T, Siontis KC, Giannopoulos G, Muthalaly RG, Liu Q, Latchamsetty R, Varga Z, Deftereos S, Swerdlow C, Callans DJ, Miller JM, Morady F, John RM, Stevenson WG. End-points for successful slow pathway catheter ablation in typical and atypical atrioventricular nodal reentrant tachycardia: a contemporary, multicenter study. JACC: Clinical Electrophysiology. 2019;5(1):113-119. http://doi.org/10.1016/j.jacep.2018.09.012.
Meles E, Carbone C, Maggiolini S, Moretti P, DE Carlini CC, Gentile G, Gnecchi-Ruscone T. A case of atrial tachycardia treated with ivabradine as bridge to ablation. Journal of Cardiovascular Electrophysiology. 2015;26(5):565-568. http://doi.org/10.1111/jce.12636.
Bohora S, Lokhandwala Y, Parekh P, Vasavda A. Reversal of tachycardiomyopathy due to left atrial tachycardia by ivabradine. Journal of Cardiovascular Electrophysiology. 2011;22(3):340-342.http://doi.org/10.1111/j.1540-8167.2010.01860.x.
Chen YL, Lin YS, Wang HT, Liu WH, Chen HC, Chen MC. Clinical outcomes of solitary atrial flutter patients using anticoagulation therapy: a national cohort study. Europace. 2019;21(2):313-321. http://doi.org/10.1093/europace/euy181.
Gillis AM, Unterberg-Buchwald C, Schmidinger H, Massimo S, Wolfe K, Kavaney DJ, Otterness MF, Hohnloser SH. Safety and efficacy of advanced atrial pacing therapies for atrial tachyarrhythmias in patients with a new implantable dual chamber cardioverter-defibrillator. Journal of the American College of Cardiology. 2002;40(9):1653-1659. http://doi.org/10.1016/s0735-1097(02)02345-8.
De Bortoli A, Shi LB, Ohm OJ, Hoff PI, Schuster P, Solheim E, Chen J. Incidence and clinical predictors of subsequent atrial fibrillation requiring additional ablation after cavotricuspid isthmus ablation for typical atrial flutter. Scandinavian Cardiovascular Journal. – 2017;51(3):123-128. http://doi.org/10.1080/14017431.2017.1304570.
Katritsis DG, Marine JE, Contreras FM, Fujii A, Latchamsetty R, Siontis KC, Katritsis GD, Zografos T, John RM, Epstein LM, Michaud GF, Anter E, Sepahpour A, Rowland E, Buxton AE, Calkins H, Morady F, Stevenson WG, Josephson ME. Catheter ablation of atypical atrioventricular nodal reentrant tachycardia. Circulation. 2016;134(21):1655-1663. http://doi.org/10.1161/CIRCULATIONAHA.116.024471.
D’Este D, Zoppo F, Bertaglia E, Zerbo F, Picciolo A, Scarabeo V, Pascotto A, Pascotto P. Long-term outcome of patients with atrioventricular node reentrant tachycardia. International Journal of Cardiology. 2007;115(3):350-353. http://doi.org/10.1016/j.ijcard.2006.04.035.
Brembilla-Perrot B, Pauriah M, Sellal JM, Zinzius PY, Schwartz J, de Chillou C, Cismaru G, Beurrier D, Voilliot D, Selton O, Louis P, Andronache M, Nosu R, de la Chaise AT. Incidence and prognostic significance of spontaneous and inducible antidromic tachycardia. Europace. 2013;15(6):871-876. http://doi.org/10.1093/europace/eus354.
Tijunelis MA, Herbert ME. Myth: intravenous amiodarone is safe in patients with atrial fibrillation and WolffParkinson-White syndrome in the emergency department. Canadian Journal of Emergency Medicine. 2005;7(4):262-265.
Pappone C, Vicedomini G, Manguso F, Saviano M, Baldi M, Pappone A, Ciaccio C, Giannelli L, Ionescu B, Petretta A, Vitale R, Cuko A, Calovic Z, Fundaliotis A, Moscatiello M, Tavazzi L, Santinelli V. Wolff-Parkinson-White syndrome in the era of catheter ablation: insights from a registry study of 2169 patients. Circulation. 2014;130(10):811-819.http://doi.org/10.1161/CIRCULATIONAHA.114.011154.
Kubuš P, Vít P, Gebauer RA, Materna O, Janoušek J. Electrophysiologic profile and results of invasive risk stratification in asymptomatic children and adolescents with the Wolff-Parkinson-White electrocardiographic pattern. Circulation Arrhythmia and Electrophysiology. 2014;7(2):218-223.http://doi.org/10.1161/CIRCEP.113.000930.
Dai C, Guo B, Li W, Xiao Y, Jin M, Han L, Dong J. The effect of ventricular pre-excitation on ventricular wall motion and left ventricular systolic function. Europace. 2018;20(7):1175-1181. http://doi.org/10.1093/europace/eux242.
Vaidya VR, Arora S, Patel N, Badheka AO, Patel N, Agnihotri K, Billimoria Z, Turakhia MP, Friedman PA, Madhavan M, Kapa S, Noseworthy PA, Cha Y-M, Gersh B, Asirvatham SJ, Deshmukh AJ. Burden of arrhythmia in pregnancy. Circulation. 2017;135(6):619-621. http://doi.org/10.1161/CIRCULATIONAHA.116.026681.
Bateman BT, Heide-Jorgensen U, Einarsdottir K, Engeland A, Furu K, Gissler M, Hernandez-Diaz S, Kieler H, Lahesmaa-Korpinen AM, Mogun H, Norgaard M, Reutfors J, Selmer R, Huybrechts KF, Zoega H. Beta-blocker use in pregnancy and the risk for congenital malformations: an international cohort study. Annals of Internal Medicine. 2018;169(10):665-673. http://doi.org/10.7326/M18-0338.
Halpern DG, Weinberg CR, Pinnelas R, Mehta-Lee S, Economy KE, Valente AM. Use of medication for cardiovascular disease during pregnancy: JACC State-of-the-Art Review. Journal of the American College of Cardiology. 2019;73(4):457-476. http://doi.org/10.1016/j.jacc.2018.10.075.
Driver K, Chisholm CA, Darby AE, Malhotra R, Dimarco JP, Ferguson JD. Catheter ablation of arrhythmia during pregnancy. Journal of Cardiovascular Electrophysiology. 2015;26(6):698-702. http://doi.org/10.1111/jce.12675.
Sohinki D, Ho J, Srinivasan N, Collins LJ, Obel OA. Outcomes after atrioventricular node ablation and biventricular pacing in patients with refractory atrial fibrillation and heart failure: a comparison between nonischaemic and ischaemic cardiomyopathy. Europace. 2014;16(6):880-886. http://doi.org/10.1093/europace/eut392.
